The cancer battle - how smaller companies are making big advancements in treatments for solid tumors

Vancouver, kelowna, and delta, british columbia--(newsfile corp. - august 12, 2024) - investorideas.com, a go-to investing platform covering biotech and medical technology issues a snapshot on recent news and developments for the treatment of solid cancer tumors, featuring aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases. read the full article at investorideas.com https://www.investorideas.com/news/2024/biotech/08120cancer-battle.asp the brainy insights estimates that the usd 222.71 billion solid tumor therapeutics market will reach usd 885.44 billion by 2033.
AEMD Ratings Summary
Quant
AEMD Quant Ranking
Sector
Industry
Quant Rating
Quant Score